telehealth subutex doctors
When you stop using an opioid like hydrocodone suddenly, you may experience unpleasant withdrawal symptoms.
If a person develops dependency as a result of long-term prescription use, their doctor may try to decrease the doses gradually to reduce the severity of the withdrawal symptoms. There are also other drugs that have been approved to treat opioid addiction, including:
Subutex and other buprenorphine products: Buprenorphine is a partial opioid agonist that works by activating opioid receptors to reduce the severity of withdrawal symptoms. Buprenorphine, being a longer-acting partial agonist medication, is less likely to be misused than many of the abused opioids it is used to treat. Buprenorphine's effects have a "limit," so even if someone tries to take more or abuse the medication, they are less likely to get the intense high they desire.
Suboxone and Zubsolv, for example, are buprenorphine and naloxone combo medications. These medications also contain naloxone, an opioid antagonist, in addition to the opioid agonist buprenorphine. Other opioids are rendered useless by opioid antagonists, which prevent them from attaching to and activating opioid receptors in the brain. When triggered, the naloxone component can also precipitate or cause rapid withdrawal symptoms, acting as a deterrent to usage. Unless the medicines are tampered with and administered, naloxone stays inactive in these combination buprenorphine preparations.
Methadone is a long-acting opioid that can be used in place of hydrocodone during detox. Methadone is normally dispensed once a day in federally supervised clinics, and it can stay in a person's system for up to 30 hours, reducing withdrawal symptoms and drug cravings. Its use should be properly supervised because it has the potential for abuse.
Vivitrol, for example, is a naltrexone product. Naltrexone, like naloxone, is an opioid antagonist that works by blocking opioid receptor sites. These medications are usually utilized after the initial phases of detox have been completed. They aid in the prevention of relapse and the prevention of future opioid misuse.